Financial and Operational Highlights: Fourth quarter 2024 worldwide da Vinci procedures grew approximately 18% compared with the fourth quarter of 2023.: Full year 2024 worldwide da Vinci procedures grew approximately 17% compared with 2023. The Company expects worldwide da Vinci procedures to increase approximately 13% to 16% in 2025 as compared to 2024. The Company placed 493 da Vinci surgical systems, of which 174 were da Vinci 5 systems, in the fourth quarter of 2024, an increase of 19% compared with 415 in the fourth quarter of 2023. During 2024, the Company placed 1,526 da Vinci surgical systems, of which 362 were da Vinci 5 systems, an increase of 11% compared with 1,370 systems in 2023. Preliminary fourth quarter 2024 revenue of approximately $2.41B increased by 25% compared with $1.93B in the fourth quarter of 2023. Preliminary 2024 revenue of approximately $8.35B increased by 17% compared with $7.12B in 2023. Fourth quarter 2024 expenses included a $45M contribution to the Intuitive Foundation compared to a $40M contribution to the Intuitive Foundation in the fourth quarter of 2023. Intuitive CEO Gary Guthart said, “We are pleased with customer adoption of da Vinci 5, Ion, and SP during the quarter and full year. We remain focused on delivering the goals we share with our customers, centered on improving patient outcomes.”
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ISRG:
- Intuitive Surgical price target raised to $655 from $650 at Bernstein
- LLY, ABT, or ISRG: Which “Strong Buy” Healthcare Stock Could Deliver the Best Returns in 2025?
- Intuitive Surgical Strengthens Leadership with Key Promotions
- Intuitive Surgical announces executive leadership promotions
- Intuitive Surgical price target raised to $530 from $490 at Evercore ISI
Questions or Comments about the article? Write to editor@tipranks.com